Drug search by name

Fondaparinux Subcutaneous and Thrombocytopenia

Result of checking the interaction of drug Fondaparinux Subcutaneous and disease Thrombocytopenia for safety when used together.

Check result:

Fondaparinux Subcutaneous <> Thrombocytopenia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Thrombocytopenia can occur with the administration of fondaparinux. Caution should be used when administered to patients with preexisting thrombocytopenia. Thrombocytopenia of any degree should be monitored closely and treatment should be discontinued if the platelet count falls below 100,000/mm3.

Fondaparinux Subcutaneous

Generic Name: fondaparinux

Brand Name: Arixtra, Arixtra 5 mg/dose, Arixtra 75 mg/dose, Arixtra 10 mg/dose

Synonyms: Fondaparinux

What is Fondaparinux Subcutaneous?